Cargando…

Tailored theranostic apolipoprotein E3 porphyrin-lipid nanoparticles target glioblastoma

The development of curative glioblastoma treatments and tumour-specific contrast agents that can overcome the blood–brain barrier (BBB) and infiltrative tumour morphology remains a challenge. Apolipoprotein E3 (apoE3) is a high density lipoprotein apolipoprotein that chaperones the transcytosis of n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajora, M. A., Ding, L., Valic, M., Jiang, W., Overchuk, M., Chen, J., Zheng, G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Royal Society of Chemistry 2017
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609152/ https://www.ncbi.nlm.nih.gov/pubmed/28970916 http://dx.doi.org/10.1039/c7sc00732a

Ejemplares similares

Correction: Tailored theranostic apolipoprotein E3 porphyrin-lipid nanoparticles target glioblastoma
por: Rajora, M. A., et al.
Publicado: (2017)

Porphyrins and Phthalocyanines for Theranostics
por: Lovell, Jonathan F., et al.
Publicado: (2012)

Tailor made magnetic nanolights: fabrication to cancer theranostics applications
por: Das, Poushali, et al.
Publicado: (2021)

Porphyrin-lipid stabilized paclitaxel nanoemulsion for combined photodynamic therapy and chemotherapy
por: Chang, Enling, et al.
Publicado: (2021)

Silver Nanoparticles Decorated with PEGylated Porphyrins as Potential Theranostic and Sensing Agents
por: Nicosia, Angelo, et al.
Publicado: (2021)

Multifunctional self-assembled peptide nanoparticles for multimodal imaging-guided enhanced theranostic applications against glioblastoma multiforme
por: Rizvi, Syed Faheem Askari, et al.
Publicado: (2021)

Theranostic nanoparticles enhance the response of glioblastomas to radiation
por: Wu, Wei, et al.
Publicado: (2019)

Targeted multimodal theranostics via biorecognition controlled aggregation of metallic nanoparticle composites
por: Hu, Xi-Le, et al.
Publicado: (2016)

Porphyrin Macrocycles: General Properties and Theranostic Potential
por: Boscencu, Rica, et al.
Publicado: (2023)

Transforming a Targeted Porphyrin Theranostic Agent into a PET Imaging Probe for Cancer
por: Shi, Jiyun, et al.
Publicado: (2011)

Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E
por: Neves, Ana Rute, et al.
Publicado: (2016)

An electronic device based on gold nanoparticles and tetraruthenated porphyrin as an electrochemical sensor for catechol
por: Sousa, Luana M., et al.
Publicado: (2017)

The Potential Application of Magnetic Nanoparticles for Liver Fibrosis Theranostics
por: Eftekhari, Aziz, et al.
Publicado: (2021)

Porphyrins as Theranostic Agents from Prehistoric to Modern Times
por: Zhang, Yumiao, et al.
Publicado: (2012)

Fullerene–porphyrin hybrid nanoparticles that generate activated oxygen by photoirradiation
por: Sugikawa, Kouta, et al.
Publicado: (2021)

Porphyrin Photoabsorption and Fluorescence Variation with Adsorptive Loading on Gold Nanoparticles
por: Shinohara, Akira, et al.
Publicado: (2021)

Theranostics Based on Magnetic Nanoparticles and Polymers: Intelligent Design for Efficient Diagnostics and Therapy
por: Gauger, Andrew J., et al.
Publicado: (2020)

Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma
por: Thomas, Eloïse, et al.
Publicado: (2017)

Protease-Activatable Porphyrin Molecular Beacon for Osteoarthritis Management
por: Walsh, Connor, et al.
Publicado: (2023)

Tumor protease-activated theranostic nanoparticles for MRI-guided glioblastoma therapy
por: Huang, Ching-Hsin, et al.
Publicado: (2023)

Tailored homo- and hetero- lanthanide porphyrin dimers: a synthetic strategy for integrating multiple spintronic functionalities into a single molecule
por: Le Roy, Jennifer J., et al.
Publicado: (2018)

Porphyrin NanoMetal-Organic Frameworks as Cancer Theranostic Agents
por: Figueira, Flávio, et al.
Publicado: (2022)

Theranostics: A treasured tailor for tomorrow
por: Jeelani, S., et al.
Publicado: (2014)

Photoresponsive Porphyrin Nanotubes of Meso-tetra(4-Sulfonatophenyl)Porphyrin and Sn(IV) meso-tetra(4-pyridyl)porphyrin
por: Koposova, Ekaterina A., et al.
Publicado: (2019)

Functionalization of theranostic AGuIX® nanoparticles for PET/MRI/optical imaging
por: Thakare, Vivek, et al.
Publicado: (2019)

Tumor microenvironment triggered biodegradation of inorganic nanoparticles for enhanced tumor theranostics
por: Yang, Weitao, et al.
Publicado: (2020)

Theranostic nanocomposite from upconversion luminescent nanoparticles and black phosphorus nanosheets
por: Dibaba, Solomon Tiruneh, et al.
Publicado: (2018)

Porphyrin-based systems containing polyaromatic fragments: decoupling the synergistic effects in aromatic-porphyrin-fullerene systems
por: Ferrero, Sergio, et al.
Publicado: (2020)

AIEgen-based theranostic system: targeted imaging of cancer cells and adjuvant amplification of antitumor efficacy of paclitaxel
por: Chen, Chao, et al.
Publicado: (2017)

Multifunctional (3-in-1) cancer theranostics applications of hydroxyquinoline-appended polyfluorene nanoparticles
por: Chowdhury, Sayan Roy, et al.
Publicado: (2017)

Advances in the Radiological Evaluation of and Theranostics for Glioblastoma
por: Hooper, Grayson W., et al.
Publicado: (2023)

Theranostic system for ratiometric fluorescence monitoring of peptide-guided targeted drug delivery
por: Rozovsky, Alex, et al.
Publicado: (2019)

Supramolecular porphyrin as an improved photocatalyst for chloroform decomposition
por: Lopes, J. M. S., et al.
Publicado: (2023)

Correction: Noninvasive target CT detection and anti-inflammation of MRSA pneumonia with theranostic silver loaded mesoporous silica
por: Zhang, Hao, et al.
Publicado: (2020)

Cyclodextrin nanoparticles in targeted cancer theranostics
por: Bose, Roshnee, et al.
Publicado: (2023)

Recombinant Interleukin-1 Receptor Antagonist Conjugated to Superparamagnetic Iron Oxide Nanoparticles for Theranostic Targeting of Experimental Glioblastoma()()()
por: Shevtsov, Maxim A., et al.
Publicado: (2015)

A biological perspective toward the interaction of theranostic nanoparticles with the bloodstream – what needs to be considered?
por: Clift, Martin J. D., et al.
Publicado: (2015)

Recent Advances in Rare-Earth-Doped Nanoparticles for NIR-II Imaging and Cancer Theranostics
por: Yu, Zhenfeng, et al.
Publicado: (2020)

Tuneable manganese oxide nanoparticle based theranostic agents for potential diagnosis and drug delivery
por: Poon, Kingsley, et al.
Publicado: (2021)

Multiscale Selectivity and in vivo Biodistribution of NRP-1-Targeted Theranostic AGuIX Nanoparticles for PDT of Glioblastoma
por: Gries, Mickaël, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m3qpe7dcrfunk9os2du85jjdnk